文献速递肾癌与肾肿瘤

肾细胞癌胚系检测的预测性临床特征

Predictive Clinical Features in Germline Testing for Renal Cell Carcinoma.
PubMed 文献 · Urology · 2025-07-30

本研究对245例接受胚系基因检测的肾细胞癌患者进行分析,评估早发、双侧多灶或家族史三个临床特征对检出致病性胚系变异的预测价值。结果显示,每增加一个特征,检出胚系变异的比值比增加近2倍,女性性别也是阳性结果的预测因素。

要点

  • 早发、双侧多灶或家族史特征可富集胚系变异阳性患者。
  • 每增加一个特征,胚系变异检出比值比增加近2倍。
  • 女性性别与胚系变异阳性结果独立相关。

核心结论

  • 具有早发、双侧多灶或家族史特征的肾细胞癌患者是胚系变异富集人群。
  • 每增加一个富集特征,检出胚系变异的比值比增加近2倍。
  • 研究结果支持在这类人群中使用胚系基因panel检测。

研究设计与样本

  • 连续纳入380例新诊断肾肿块且无遗传性肾癌综合征个人或家族史的患者,其中245例接受胚系基因panel检测并纳入分析。
  • 评估3个临床富集特征(早发、双侧多灶、家族史)对检出致病/可能致病性变异的预测准确性。

主要发现

  • 245例中217例至少具有1个富集特征,包括106例早发、144例双侧多灶、62例家族史。
  • panel结果阳性33例(13.5%),阴性171例(69.8%),意义不明变异41例(16.7%)。
  • 阳性比例随特征数量增加:无特征7.1%,1个特征11.3%,2个特征16.4%,3个特征36.4%。

临床怎么用

  • 对具有早发、双侧多灶或家族史特征的肾细胞癌患者,应考虑进行胚系基因panel检测。
  • 女性患者若合并上述特征,胚系变异检出可能性更高,可优先考虑检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize the frequency of germline alterations in a potentially enriched renal cell carcinoma (RCC) population, including early onset (EO), bilateral multifocal (BMF), or those with a family history of renal cancer (FRC). METHODS: We identified 380 consecutive patients referred with a new diagnosis of a renal mass without a personal or family history of a hereditary RCC syndrome, of which 245 underwent a germline genetic panel and were included in the analysis. The predictive accuracy of 3 clinical enrichment features (EO, BMF, and FRC) and the likelihood of identifying a pathogenic/likely pathogenic variant were assessed. RESULTS: Of the 245 patients, 217 had at least 1 of the 3 enrichment features, including 106 with EO, 144 with BMF, and 62 with FRC. Panel results were positive in 33 (13.5%) patients, negative in 171 (69.8%), or reported a variant of uncertain significance in 41 (16.7%). More than 1 enrichment feature increased the proportion of positive results: 7.1% with no features, 11.3% with 1 feature, 16.4% with 2 features, and 36.4% with 3 features. For each additional enrichment feature, the odds of identifying a germline variant increase by nearly 2-fold (odds ratio = 1.82 [95% confidence interval: 1.10-3.05] P = .02). Female sex was also predictive of positive panel results (odds ratio = 2.80 [95% confidence interval: 1.24-6.67] P = .015) on multivariate analysis. CONCLUSION: Patients presenting with EO, BMF, or FRC are enriched populations with more frequent positive germline RCC alterations. The odds of a germline alteration nearly double with each additional enrichment feature. These findings support the use of germline gene panel testing in these populations.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Rompré-Brodeur A, Gopal N, Millan B, et al. Predictive Clinical Features in Germline Testing for Renal Cell Carcinoma. Urology. 2025. PMID: 40750025. doi:10.1016/j.urology.2025.07.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。